World's Best Scientists 2026 revealed!
Thomas B. Issekutz

Thomas B. Issekutz

D-Index & Metrics

Immunology

D-Index
58
Citations
9884
World Ranking
3558
National Ranking
92

Thomas B. Issekutz publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Thomas B. Issekutz sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 167 publications — 22nd percentile

22% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Thomas B. Issekutz D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Thomas B. Issekutz sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 58 D-Index — 30th percentile

30% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Thomas B. Issekutz is affiliated with Dalhousie University in Canada and has contributed extensively to research within the fields of Medicine, Immunology and Microbiology, and Biochemistry, Genetics and Molecular Biology. Their work spans various subfields including Immunology, Genetics, Hematology, Rheumatology, and Oncology.

The scientist's research covers a diverse range of main topics such as Immunodeficiency and Autoimmune Disorders, Immune Cell Function and Interaction, Blood disorders and treatments, Autoimmune and Inflammatory Disorders Research, Blood groups and transfusion, Rheumatoid Arthritis Research and Therapies, and Systemic Lupus Erythematosus Research.

Frequent coauthors collaborating with Thomas B. Issekutz include Beáta Dérfalvi, Sarah M. McAlpine, Drew Slauenwhite, Anikó Malik, and Jean S. Marshall.

Common venues for publication include Frontiers in Immunology, Clinical Immunology, Allergy Asthma and Clinical Immunology, Arthritis & Rheumatology, and The Journal of Rheumatology.

Key recent papers authored or coauthored by Thomas B. Issekutz include:

  • Prolidase deficiency, a rare inborn error of immunity, clinical phenotypes, immunological features, and proposed treatments in twins (2022) published in Allergy Asthma and Clinical Immunology
  • High Dose Intravenous IgG Therapy Modulates Multiple NK Cell and T Cell Functions in Patients With Immune Dysregulation (2021) published in Frontiers in Immunology
  • Association of a Type 2-Polarized T Cell Phenotype With Methotrexate Nonresponse in Patients With Rheumatoid Arthritis (2020) published in Arthritis & Rheumatology
  • Clinical exome sequencing data from patients with inborn errors of immunity: Cohort level diagnostic yield and the benefit of systematic reanalysis (2024) published in Clinical Immunology
  • Differentially Expressed Inflammation-Regulating MicroRNAs in Oligoarticular Juvenile Idiopathic Arthritis (2022) published in The Journal of Rheumatology

Best Publications

  • Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions

    Ingo Bartholomäus;Naoto Kawakami;Francesca Odoardi;Christian Schläger

  • Effector T-cell trafficking between the leptomeninges and the cerebrospinal fluid

    Christian Schläger;Henrike Körner;Martin Krueger;Stefano Vidoli

  • Inhibition of in vivo lymphocyte migration to inflammation and homing to lymphoid tissues by the TA-2 monoclonal antibody. A likely role for VLA-4 in vivo.

    T B Issekutz

  • Primary immunodeficiency diseases: Genomic approaches delineate heterogeneous Mendelian disorders.

    Asbjørg Stray-Pedersen;Hanne Sørmo Sorte;Pubudu Samarakoon;Tomasz Gambin;Tomasz Gambin

  • Chronic inflammation upregulates chemokine receptors and induces neutrophil migration to monocyte chemoattractant protein-1

    Brent Johnston;Alan R. Burns;Makoto Suematsu;Thomas B. Issekutz

  • Requirements for leukocyte adhesion molecules in nephrotoxic nephritis.

    M S Mulligan;K J Johnson;rd R F Todd;T B Issekutz

  • Lymphocyte recruitment in delayed-type hypersensitivity. The role of IFN-gamma.

    T B Issekutz;J M Stoltz;P vd Meide

  • Role of CD11a and CD11b in ischemic acute renal failure in rats

    H. Rabb;C. C. Mendiola;J. Dietz;S. R. Saba

  • Role of β1 β2 integrins and ICAM-1 in lung injury after deposition of IgG and IgA immune complexes

    M S Mulligan;G P Wilson;R F Todd;C W Smith

  • Unexpected role of surface transglutaminase type II in celiac disease

    Luigi Maiuri;Carolina Ciacci;Ida Ricciardelli;Loredana Vacca

  • The in vivo quantitation and kinetics of monocyte migration into acute inflammatory tissue.

    Issekutz Tb;Issekutz Ac;Movat Hz

  • In vivo blood monocyte migration to acute inflammatory reactions, IL-1 alpha, TNF-alpha, IFN-gamma, and C5a utilizes LFA-1, Mac-1, and VLA-4. The relative importance of each integrin.

    T B Issekutz

  • Human mast cell activation with virus-associated stimuli leads to the selective chemotaxis of natural killer cells by a CXCL8-dependent mechanism.

    Sarah M Burke;Thomas B Issekutz;Karkada Mohan;Patrick W K Lee

  • Rat Blood Neutrophils Express Very Late Antigen 4 and it Mediates Migration to Arthritic Joint and Dermal Inflammation

    Thomas B. Issekutz;Masayuki Miyasaka;Andrew C. Issekutz

  • The alpha 4-integrin supports leukocyte rolling and adhesion in chronically inflamed postcapillary venules in vivo.

    Brent Johnston;Thomas B. Issekutz;Paul Kubes

  • L-selectin stimulation enhances functional expression of surface CXCR4 in lymphocytes: implications for cellular activation during adhesion and migration

    Ziqiang Ding;Thomas B. Issekutz;Gregory P. Downey;Thomas K. Waddell

  • The alpha 4 beta 1 (very late antigen (VLA)-4, CD49d/CD29) and alpha 5 beta 1 (VLA-5, CD49e/CD29) integrins mediate beta 2 (CD11/CD18) integrin-independent neutrophil recruitment to endotoxin-induced lung inflammation.

    J A Burns;T B Issekutz;H Yagita;A C Issekutz

  • The Use of Immunoglobulin Therapy for Patients With Primary Immune Deficiency: An Evidence-Based Practice Guideline

    Nadine Shehata;Valerie Palda;Tom Bowen;Elie Haddad

  • Blockade of Chemokine Receptor CXCR3 Inhibits T Cell Recruitment to Inflamed Joints and Decreases the Severity of Adjuvant Arthritis

    Karkada Mohan;Thomas B. Issekutz

  • Effect of a new monoclonal antibody, TA-2, that inhibits lymphocyte adherence to cytokine stimulated endothelium in the rat.

    T B Issekutz;A Wykretowicz

  • Role of leukocyte adhesion molecules in lung and dermal vascular injury after thermal trauma of skin.

    M. S. Mulligan;G. O. Till;C. W. Smith;D. C. Anderson

Frequent Co-Authors

Andrew C. Issekutz
Andrew C. Issekutz Dalhousie University
Jean S. Marshall
Jean S. Marshall Dalhousie University
Masayuki Miyasaka
Masayuki Miyasaka Osaka University
Paul Kubes
Paul Kubes University of Calgary
Stuart E. Turvey
Stuart E. Turvey University of British Columbia
Elie Haddad
Elie Haddad University of Montreal
Stefan Feske
Stefan Feske New York University
Takuya Tamatani
Takuya Tamatani Japan Tobacco (United States)
Bertrand Boisson
Bertrand Boisson Rockefeller University
Capucine Picard
Capucine Picard Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in advancing their careers in immunology or healthcare, pursuing related online degrees can open doors to diverse opportunities. Many professionals start with nursing degrees, such as an online absn programs for non nurses, which provide accelerated pathways for individuals without a nursing background. These programs offer a swift entry into the healthcare field.

Once in nursing, students can explore the accelerated fnp programs to become Family Nurse Practitioners (FNPs), gaining advanced clinical skills that complement immunology expertise. For nurses aiming to specialize further, obtaining acute care np certification is a key step, enabling them to handle critically ill patients and work in high-intensity environments.

Additionally, some students prefer entry points with flexible admission standards. Exploring the easiest accelerated nursing programs can help individuals find suitable options with less competitive barriers, fostering a smooth transition into nursing careers closely tied to immunological practice.

Choosing the right pathway depends on your background and career goals, but these online degree options provide vital stepping stones towards impactful roles in immunology and healthcare.

Best Scientists Citing Thomas B. Issekutz

Trending Scientists

Recently Published Articles